---
title: "Ganyue Expressway released its semi-annual performance, with a net profit attributable to the parent company of 764 million yuan, a year-on-year increase of 21.8%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253045698.md"
description: "According to the Zhitong Finance APP, Ganyue Expressway disclosed its semi-annual report for 2025. During the reporting period, the company achieved revenue of 3.081 billion yuan, a year-on-year decrease of 4.32%; the net profit attributable to shareholders of the listed company was 764 million yuan, a year-on-year increase of 21.8%; the net profit excluding non-recurring gains and losses was 626 million yuan, a year-on-year decrease of 3.83%; the basic earnings per share were 0.33 yuan"
datetime: "2025-08-14T12:28:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253045698.md)
  - [en](https://longbridge.com/en/news/253045698.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253045698.md)
---

# Ganyue Expressway released its semi-annual performance, with a net profit attributable to the parent company of 764 million yuan, a year-on-year increase of 21.8%

According to the Zhitong Finance APP, Ganyue Expressway (600269.SH) disclosed its semi-annual report for 2025. During the reporting period, the company achieved revenue of 3.081 billion yuan, a year-on-year decrease of 4.32%; the net profit attributable to shareholders of the listed company was 764 million yuan, a year-on-year increase of 21.8%; the net profit excluding non-recurring gains and losses was 626 million yuan, a year-on-year decrease of 3.83%; the basic earnings per share were 0.33 yuan

### Related Stocks

- [600269.CN](https://longbridge.com/en/quote/600269.CN.md)

## Related News & Research

- [‘It’s Not That Simple,’ Says Investor About Micron Stock](https://longbridge.com/en/news/296022896.md)
- [Sabadell director general Marcos Prat sells EUR 543,000 worth of shares](https://longbridge.com/en/news/296251094.md)
- [PRESS DIGEST-Canada - August 18](https://longbridge.com/en/news/296230256.md)
- [PFSE: Record Q2 revenue and profit growth, driven by strong demand and innovation in HVDC technology](https://longbridge.com/en/news/296308264.md)
- [IMMU: Vididencel delivers durable remissions in AML and CML, with broad late-stage clinical expansion](https://longbridge.com/en/news/296462827.md)